CHRISTINE CARTER: Open Payments
NPI 1912590407 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 44 payments from 19 companies in 2025. Trend: 2023 $742 · 2024 $1,699 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $102 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| United Therapeutics Corporation | 3 | $88 |
| GENZYME CORPORATION | 3 | $73 |
| Inspire Medical Systems, Inc. | 2 | $53 |
| Collegium Pharmaceutical, Inc. | 2 | $45 |
| JAZZ PHARMACEUTICALS INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $37 |
| Insmed, Inc. | 2 | $34 |
Products named: NUCALA, Tyvaso, DUPIXENT, OFEV, FASENRA, INSPIRE, Jornay PM, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
